ArticleAmerican journal of hematology2025

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.

Nilanjan Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.